A stable 1:1 lithium acylcyanocuprate. Dependence of the stability of acylcyanocuprates on the nature of the alkyl substituent.
作者:Dietmar Seyferth、Richard C. Hui
DOI:10.1016/s0040-4039(00)84288-4
日期:1986.1
Acylcuprates obtained by carbonylation of R(CN)CuLi cuprates (R = t-Bu, sec-Bu) at low temperature are effective in the directnucleophilic1,4-acylation of α,β-unsaturated ketones and aldehydes. The R = t-Bu reagent is sufficiently stable so that it can be used even at room temparature. The R = sec-Bu reagent is best used at −110°C.
Formation of β-Substituted γ-Keto Esters via Zinc Carbenoid Mediated Chain Extension
作者:Charles Zercher、Weimin Lin、Robert McGinness、Emerald Wilson
DOI:10.1055/s-2007-965886
日期:2007.7
The conversion of β-keto esters into β-methylated γ-keto esters can be achieved through treatment with zinc carbenoids derived- from 1,1-diiodoethane. The incorporation of a β-phenyl substituent is also possible through treatment with diiodotoluene.
SEYFERTH, D.;HUI, R. C., TETRAHEDRON LETT., 1986, 27, N 13, 1473-1476
作者:SEYFERTH, D.、HUI, R. C.
DOI:——
日期:——
PYRROLE COMPOUNDS AS GRANZYME B INHIBITORS
申请人:viDA Therapeutics Inc.
公开号:US20170015705A1
公开(公告)日:2017-01-19
Pyrrole compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Method for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.
PROLINE COMPOUNDS AS GRANZYME B INHIBITORS
申请人:viDA Therapeutics Inc.
公开号:US20170015706A1
公开(公告)日:2017-01-19
Proline compounds as Granzyme B inhibitors, compositions that include the compounds, and methods for using the compounds. Methods for treating cutaneous scleroderma, epidermolysis bullosa, radiation dermatitis, alopecia areata, and discoid lupus erythematosus are provided.